Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2000 | 09-2000 | 06-2000 | |
| Cash Flows From Operating Activities | |||
| Net Income | -80 | N/A | N/A |
| Depreciation Amortization | 1 | N/A | N/A |
| Accounts payable and accrued liabilities | -4 | N/A | N/A |
| Other Working Capital | -4 | N/A | N/A |
| Other Operating Activity | 15 | -32 | -32 |
| Operating Cash Flow | $-73 | $-32 | $-32 |
| Cash Flows From Investing Activities | |||
| Purchase Sale Intangibles | -2 | -2 | -2 |
| Other Investing Activity | -2 | -2 | -2 |
| Investing Cash Flow | $-3 | $-3 | $-3 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 101 | 101 | 101 |
| Financing Cash Flow | $101 | $101 | $101 |
| Beginning Cash Position | 1 | 1 | 1 |
| End Cash Position | 27 | 67 | 67 |
| Net Cash Flow | $26 | $66 | $66 |
| Free Cash Flow | |||
| Operating Cash Flow | -73 | -32 | -32 |
| Free Cash Flow | -73 | -33 | -33 |